Ascendis Pharma A/S (ASND)
NASDAQ·Healthcare·Biotechnology
$255.01
-0.69%
Mkt Cap $14.73B
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (55 analysts)
$320.36
Range $273.00 – $345.00
Implied Upside
+25.6%
Consensus $320.36 vs current $255.01
NASDAQ·Healthcare·Biotechnology
$255.01
-0.69%
Mkt Cap $14.73B
Buy
1
Hold
0
Sell
0
Price Target (55 analysts)
$320.36
Range $273.00 – $345.00
+25.6%
Consensus $320.36 vs current $255.01